HomeWebinarsKnockout Screening with Sanger Arrayed Genome-Wide CRISPR Libraries

Knockout Screening with Sanger Arrayed Genome-Wide CRISPR Libraries


Here we present the first genome wide, arrayed guide RNA screening libraries for CRISPR-Cas9. These libraries have been designed to cover 17166 human and 20430 mouse genes. To test the efficiency, we selected gRNAs targeting genes from the GPI anchor protein pathway. We observed that over 95% of these gRNAs successfully induced DNA cleavage and consequently gene loss of function. These libraries offer the prospect for performing high-throughput screens for genes of considerable scientific and therapeutic value in mouse and human cells.


Emmanouil Metzakopian, PhD

Wellcome Trust Sanger Institute

WTSI Career Development Fellow PDUK Senior Research Fellow

Dr. Metzakopian is a research fellow at Wellcome Trust Sanger Institute, where he focuses on identifying genes which confer resistance to chemotherapy drugs in embryonic stem cells and to oxidative stress agents in dopamine neurons.

Shawn Shafer, PhD


Advanced Genomics Market Segment Manager

Dr. Shafer leads a team responsible for product development of Merck’s RNAi and genome editing portfolios. He orchestrated the creation of Merck CRISPR collection of reagents.

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.